688626 翔宇医疗
已收盘 01-06 15:00:01
资讯
新帖
简况
股市必读:翔宇医疗(688626)登1月6日交易所龙虎榜
证券之星 · 03:37
股市必读:翔宇医疗(688626)登1月6日交易所龙虎榜
2连板翔宇医疗:目前主要聚焦非侵入式脑机接口技术截至2025年末尚未实现规模化销售
证券之星 · 01-06 19:01
2连板翔宇医疗:目前主要聚焦非侵入式脑机接口技术截至2025年末尚未实现规模化销售
异动快报:翔宇医疗(688626)1月6日9点34分触及涨停板
中金财经 · 01-06 09:48
异动快报:翔宇医疗(688626)1月6日9点34分触及涨停板
马斯克放出“量产时间表”,脑机接口集体涨停,商业化拐点来了?
华尔街见闻 · 01-05 15:50
马斯克放出“量产时间表”,脑机接口集体涨停,商业化拐点来了?
异动快报:翔宇医疗(688626)1月5日9点34分触及涨停板
证券之星 · 01-05 09:36
异动快报:翔宇医疗(688626)1月5日9点34分触及涨停板
翔宇医疗(688626)披露为全资子公司提供担保的进展公告,12月10日股价下跌1.17%
证券之星 · 2025-12-10
翔宇医疗(688626)披露为全资子公司提供担保的进展公告,12月10日股价下跌1.17%
翔宇医疗:公司不存在逾期担保情况
证券日报 · 2025-12-10
翔宇医疗:公司不存在逾期担保情况
翔宇医疗(688626)公司公告取消监事会并修订公司章程,11月24日股价上涨1.87%
证券之星 · 2025-11-24
翔宇医疗(688626)公司公告取消监事会并修订公司章程,11月24日股价上涨1.87%
每周股票复盘:翔宇医疗(688626)拟取消监事会并为子公司担保4亿元
证券之星 · 2025-11-16
每周股票复盘:翔宇医疗(688626)拟取消监事会并为子公司担保4亿元
翔宇医疗(688626)披露拟取消监事会并增设职工代表董事,11月14日股价下跌0.87%
证券之星 · 2025-11-14
翔宇医疗(688626)披露拟取消监事会并增设职工代表董事,11月14日股价下跌0.87%
翔宇医疗(688626)2025年三季报简析:增收不增利,公司应收账款体量较大
证券之星 · 2025-11-01
翔宇医疗(688626)2025年三季报简析:增收不增利,公司应收账款体量较大
图解翔宇医疗三季报:第三季度单季净利润同比下降48.82%
证券之星 · 2025-10-31
图解翔宇医疗三季报:第三季度单季净利润同比下降48.82%
翔宇医疗新注册《步态和平衡评估训练系统V1》项目的软件著作权
证券之星 · 2025-10-15
翔宇医疗新注册《步态和平衡评估训练系统V1》项目的软件著作权
翔宇医疗新注册《认知障碍康复评估训练系统V1》项目的软件著作权
证券之星 · 2025-10-10
翔宇医疗新注册《认知障碍康复评估训练系统V1》项目的软件著作权
9月23日翔宇医疗跌5.95%,博时健康成长双周定期可赎回混合A基金重仓该股
证券之星 · 2025-09-23
9月23日翔宇医疗跌5.95%,博时健康成长双周定期可赎回混合A基金重仓该股
翔宇医疗新注册《针灸机器人软件V1》项目的软件著作权
证券之星 · 2025-09-15
翔宇医疗新注册《针灸机器人软件V1》项目的软件著作权
每周股票复盘:翔宇医疗(688626)脑机接口产品2025年贡献业绩
证券之星 · 2025-09-07
每周股票复盘:翔宇医疗(688626)脑机接口产品2025年贡献业绩
【机构调研记录】鑫元基金调研翔宇医疗、复旦微电等3只个股(附名单)
证券之星 · 2025-09-05
【机构调研记录】鑫元基金调研翔宇医疗、复旦微电等3只个股(附名单)
翔宇医疗:9月3日召开业绩说明会,包括知名机构趣时资产的多家机构参与
证券之星 · 2025-09-04
翔宇医疗:9月3日召开业绩说明会,包括知名机构趣时资产的多家机构参与
9月2日翔宇医疗跌5.87%,博时健康成长双周定期可赎回混合A基金重仓该股
证券之星 · 2025-09-02
9月2日翔宇医疗跌5.87%,博时健康成长双周定期可赎回混合A基金重仓该股
加载更多
公司概况
公司名称:
河南翔宇医疗设备股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-03-31
主营业务:
河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。公司是同行业率先通过ISO9001和YY/T0287idtISO13485医疗器械质量管理体系、ISO14001环境管理体系、OHSAS18001职业健康安全管理体系和知识产权管理五个体系认证的企业。报告期末,公司已获得专利1,933项,参与起草或参与评定36个国家行业标准,获得省级科技成果248项。
发行价格:
28.82
{"stockData":{"symbol":"688626","market":"SH","secType":"STK","nameCN":"翔宇医疗","latestPrice":87.12,"timestamp":1767682801000,"preClose":72.6,"halted":0,"volume":8632619,"delay":0,"changeRate":0.2,"floatShares":160000000,"shares":160000000,"eps":0.4595,"marketStatus":"已收盘","change":14.52,"latestTime":"01-06 15:00:01","open":82.76,"high":87.12,"low":82.06,"amount":742000000,"amplitude":0.0697,"askPrice":0,"askSize":0,"bidPrice":87.12,"bidSize":8765,"shortable":0,"etf":0,"ttmEps":0.4595,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767749400000},"marketStatusCode":5,"adr":0,"adjPreClose":72.6,"symbolType":"stock_kcb","openAndCloseTimeList":[[1767663000000,1767670200000],[1767675600000,1767682800000]],"highLimit":79.86,"lowLimit":65.34,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"isCdr":false,"pbRate":6.88,"roa":"--","peRate":189.597388,"roe":"2.09%","epsLYR":0.66,"committee":0,"marketValue":13939000000,"turnoverRate":0.054,"status":0,"afterMarket":{"amount":463652.64,"volume":5322,"close":87.12,"buyVolume":20627,"sellVolume":0,"time":1767684837558,"indexStatus":"已收盘 01-06 15:30:00","preClose":72.6},"floatMarketCap":13939000000},"requestUrl":"/m/hq/s/688626","defaultTab":"news","newsList":[{"id":"2601810334","title":"股市必读:翔宇医疗(688626)登1月6日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2601810334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601810334?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:37","pubTimestamp":1767728230,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,翔宇医疗报收于87.12元,上涨20.0%,已连续涨停2天,换手率5.4%,成交量8.63万手,成交额7.42亿元。来自龙虎榜上榜:翔宇医疗因单日涨幅达15%且三日累计涨幅偏离值达30%,登龙虎榜。龙虎榜上榜沪深交易所2026年1月6日公布的交易公开信息显示,翔宇医疗因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券,有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2601993748","title":"2连板翔宇医疗:目前主要聚焦非侵入式脑机接口技术截至2025年末尚未实现规模化销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601993748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601993748?lang=zh_cn&edition=full","pubTime":"2026-01-06 19:01","pubTimestamp":1767697288,"startTime":"0","endTime":"0","summary":"公司目前主要聚焦非侵入式脑机接口技术,覆盖作业疗法、运动疗法、认知言语、吞咽等康复全场景布局,与当前国际上的侵入式脑机接口技术路线存在差异。公司在脑机接口方面的投入,目前在技术、产品、渠道市场等方面形成一定的布局,但招投标和销售等具有滞后性,截至2025年末,相关产品尚未实现规模化销售,营收占比较小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600035600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2601546958","title":"异动快报:翔宇医疗(688626)1月6日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601546958","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601546958?lang=zh_cn&edition=full","pubTime":"2026-01-06 09:48","pubTimestamp":1767664099,"startTime":"0","endTime":"0","summary":"证券之星1月6日盘中消息,9点34分翔宇医疗触及涨停板。其所属行业医疗器械目前上涨。领涨股为博拓生物。该股为脑科学,医疗器械,养老产业概念热股,当日脑科学概念上涨6.53%,医疗器械概念上涨1.66%,养老产业概念上涨0.76%。1月5日的资金流向数据方面,主力资金净流入6959.42万元,占总成交额17.68%,游资资金净流出4895.45万元,占总成交额12.44%,散户资金净流出2063.96万元,占总成交额5.24%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/06/20260106282678.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/06/20260106282678.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260106/31918277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2601910003","title":"马斯克放出“量产时间表”,脑机接口集体涨停,商业化拐点来了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601910003","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601910003?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:50","pubTimestamp":1767599456,"startTime":"0","endTime":"0","summary":"随着马斯克明确给出Neuralink设备2026年启动量产的时间表,脑机接口行业或将迎来从“医疗试验品”向“大众消费品”跨越的关键转折点。市场正对脑机接口在医疗康复、AI互联及人形机器人协同等领域广阔应用前景进行重估。大摩预测,到2045年整个市场规模将跃升至3200亿美元。","market":"sh","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3762545","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"a3b3ff8b53102d7bfda203f04641d58f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3762545","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301293","688626","301363"],"gpt_icon":1},{"id":"2601751180","title":"异动快报:翔宇医疗(688626)1月5日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601751180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601751180?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:36","pubTimestamp":1767576997,"startTime":"0","endTime":"0","summary":"证券之星1月5日盘中消息,9点34分翔宇医疗触及涨停板。其所属行业医疗器械目前下跌。领涨股为明德生物。该股为脑科学,养老产业,医疗器械概念热股,当日脑科学概念上涨6.02%,养老产业概念上涨1.17%,医疗器械概念上涨0.92%。12月31日的资金流向数据方面,主力资金净流入1273.83万元,占总成交额6.85%,游资资金净流入143.76万元,占总成交额0.77%,散户资金净流出1417.59万元,占总成交额7.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500004237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2590053822","title":"翔宇医疗(688626)披露为全资子公司提供担保的进展公告,12月10日股价下跌1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590053822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590053822?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:19","pubTimestamp":1765376380,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘,翔宇医疗报收于48.1元,较前一交易日下跌1.17%,最新总市值为76.96亿元。该股当日开盘48.6元,最高48.85元,最低47.23元,成交额达3737.13万元,换手率为0.49%。公司近日发布公告称,河南翔宇医疗设备股份有限公司为全资子公司河南瑞贝塔医疗科技有限公司向华夏银行股份有限公司郑州分行申请的不超过10,000.00万元贷款提供连带责任担保。截至公告日,公司及控股子公司对外担保总额为10,000.00万元,占公司最近一期经审计净资产的4.91%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2590538649","title":"翔宇医疗:公司不存在逾期担保情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538649","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590538649?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:42","pubTimestamp":1765374120,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月10日晚间,翔宇医疗发布公告称,截至本公告披露日,公司不存在逾期担保情况或涉及诉讼的担保情况。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-10/doc-inhaiqhx0336497.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-10/doc-inhaiqhx0336497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2585517498","title":"翔宇医疗(688626)公司公告取消监事会并修订公司章程,11月24日股价上涨1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585517498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585517498?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:27","pubTimestamp":1763994475,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘,翔宇医疗报收于45.7元,较前一交易日上涨1.87%,最新总市值为73.12亿元。该股当日开盘45.53元,最高46.2元,最低45.0元,成交额达3981.48万元,换手率为0.55%。出席会议的股东共74人,代表表决权股份114,629,702股,占公司总表决权的73.4476%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2583670654","title":"每周股票复盘:翔宇医疗(688626)拟取消监事会并为子公司担保4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583670654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583670654?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:48","pubTimestamp":1763239689,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,翔宇医疗报收于51.18元,较上周的50.95元上涨0.45%。本周,翔宇医疗11月10日盘中最高价报52.88元。本周关注点公司公告汇总:翔宇医疗拟取消监事会,增设1名职工代表董事,董事会成员由5名增至6名。翔宇医疗拟为全资子公司河南瑞贝塔医疗科技有限公司提供不超过40,000.00万元的不可撤销连带责任担保,用于其向金融机构申请贷款。截至目前,公司及控股子公司对外担保总额为0万元,无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2583507827","title":"翔宇医疗(688626)披露拟取消监事会并增设职工代表董事,11月14日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583507827","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583507827?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:58","pubTimestamp":1763132306,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,翔宇医疗报收于51.18元,较前一交易日下跌0.87%,最新总市值为81.89亿元。该股当日开盘51.3元,最高52.3元,最低51.02元,成交额达5838.71万元,换手率为0.71%。公司近日发布公告称,拟取消监事会,增设1名职工代表董事,董事会成员由5名增至6名,并由董事会审计委员会行使监事会职权。该事项已由第三届董事会第七次会议及第三届监事会第七次会议审议通过,尚需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400042287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2580141761","title":"翔宇医疗(688626)2025年三季报简析:增收不增利,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2580141761","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580141761?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:53","pubTimestamp":1761951200,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期翔宇医疗发布2025年三季报。截至本报告期末,公司营业总收入5.37亿元,同比上升6.0%,归母净利润4398.15万元,同比下降40.09%。本报告期翔宇医疗公司应收账款体量较大,当期应收账款占最新年报归母净利润比达71.51%。然而去年的净利率为13.83%,算上全部成本后,公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100008061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2579208175","title":"图解翔宇医疗三季报:第三季度单季净利润同比下降48.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579208175","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579208175?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:46","pubTimestamp":1761849989,"startTime":"0","endTime":"0","summary":"证券之星消息,翔宇医疗2025年三季报显示,前三季度公司主营收入5.37亿元,同比上升6.0%;归母净利润4398.15万元,同比下降40.09%;扣非净利润2993.96万元,同比下降53.54%;其中2025年第三季度,公司单季度主营收入1.78亿元,同比上升5.46%;单季度归母净利润858.69万元,同比下降48.82%;单季度扣非净利润690.6万元,同比下降37.21%;负债率37.63%,投资收益613.49万元,财务费用-992.92万元,毛利率67.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100003030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"gpt_icon":0},{"id":"2575454102","title":"翔宇医疗新注册《步态和平衡评估训练系统V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2575454102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575454102?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:48","pubTimestamp":1760464096,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗新注册了《步态和平衡评估训练系统V1》项目的软件著作权。今年以来翔宇医疗新注册软件著作权23个,较去年同期增加了53.33%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了8423.16万元,同比增28.27%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了42家企业,参与招投标项目2651次;财产线索方面有商标信息152条,专利信息2338条,著作权信息102条;此外企业还拥有行政许可588个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500001247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2574198922","title":"翔宇医疗新注册《认知障碍康复评估训练系统V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2574198922","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574198922?lang=zh_cn&edition=full","pubTime":"2025-10-10 01:49","pubTimestamp":1760032158,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗新注册了《认知障碍康复评估训练系统V1》项目的软件著作权。今年以来翔宇医疗新注册软件著作权22个,较去年同期增加了46.67%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了8423.16万元,同比增28.27%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了42家企业,参与招投标项目2642次;财产线索方面有商标信息152条,专利信息2348条,著作权信息101条;此外企业还拥有行政许可588个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000001413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2569986747","title":"9月23日翔宇医疗跌5.95%,博时健康成长双周定期可赎回混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2569986747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569986747?lang=zh_cn&edition=full","pubTime":"2025-09-23 16:28","pubTimestamp":1758616130,"startTime":"0","endTime":"0","summary":"证券之星消息,9月23日翔宇医疗跌5.95%,收盘报50.58元,换手率2.14%,成交量3.42万手,成交额1.75亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为博时基金的博时健康成长双周定期可赎回混合A。博时健康成长双周定期可赎回混合A目前规模为3.75亿元,最新净值1.0139,较上一交易日上涨0.99%,近一年上涨42.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300025808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2567025154","title":"翔宇医疗新注册《针灸机器人软件V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2567025154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567025154?lang=zh_cn&edition=full","pubTime":"2025-09-15 01:52","pubTimestamp":1757872337,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗新注册了《针灸机器人软件V1》项目的软件著作权。今年以来翔宇医疗新注册软件著作权21个,较去年同期增加了133.33%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了8423.16万元,同比增28.27%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了42家企业,参与招投标项目2545次;财产线索方面有商标信息152条,专利信息2330条,著作权信息100条;此外企业还拥有行政许可588个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500000643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2565432825","title":"每周股票复盘:翔宇医疗(688626)脑机接口产品2025年贡献业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2565432825","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565432825?lang=zh_cn&edition=full","pubTime":"2025-09-07 05:30","pubTimestamp":1757194236,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,翔宇医疗报收于55.25元,较上周的55.2元上涨0.09%。本周,翔宇医疗9月2日盘中最高价报58.99元。翔宇医疗当前最新总市值88.4亿元,在医疗器械板块市值排名42/126,在两市A股市值排名2046/5152。针对特定产品或训练部位,康复效果优于传统方式,推动患者向“主动康复”转变。搭载脑机接口技术的新产品陆续取证上市,2025年将贡献业绩,2026年预计对业绩提升起较大促进作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2565292581","title":"【机构调研记录】鑫元基金调研翔宇医疗、复旦微电等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2565292581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565292581?lang=zh_cn&edition=full","pubTime":"2025-09-05 08:05","pubTimestamp":1757030747,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及9月4日披露的机构调研信息,鑫元基金近期对3家上市公司进行了调研,相关名单如下:1)翔宇医疗 调研纪要:脑机接口在康复医疗领域前景明确,有望推动患者从“被动康复”向“主动康复”转变,节省人力成本、提升效果,逐渐获院端和患者认可。2)复旦微电 调研纪要:2025年半年度FPGA产品线毛利率约75%,公司将持续通过技术迭代维持竞争优势。2025年上半年跨境电商收入同比增长82.8%,保持盈利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500006468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688385","BK0214","688626","BK0251"],"gpt_icon":0},{"id":"2564726379","title":"翔宇医疗:9月3日召开业绩说明会,包括知名机构趣时资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2564726379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564726379?lang=zh_cn&edition=full","pubTime":"2025-09-04 19:34","pubTimestamp":1756985695,"startTime":"0","endTime":"0","summary":"公司2015年开始脑电相关研究,多次参与国家重大研发专项积累技术能力。其中包括多项涉及到脑机接口的发明专利、软件著作权、注册证等,还有多项处于申报中。翔宇医疗主营业务:康复医疗器械的研发、生产与销售。翔宇医疗2025年中报显示,公司主营收入3.59亿元,同比上升6.27%;归母净利润3539.47万元,同比下降37.5%;扣非净利润2303.37万元,同比下降56.9%;其中2025年第二季度,公司单季度主营收入1.73亿元,同比上升2.51%;单季度归母净利润124","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400032928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2564872771","title":"9月2日翔宇医疗跌5.87%,博时健康成长双周定期可赎回混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564872771","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564872771?lang=zh_cn&edition=full","pubTime":"2025-09-02 16:35","pubTimestamp":1756802152,"startTime":"0","endTime":"0","summary":"证券之星消息,9月2日翔宇医疗跌5.87%,收盘报54.87元,换手率2.93%,成交量4.69万手,成交额2.62亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为博时基金的博时健康成长双周定期可赎回混合A。博时健康成长双周定期可赎回混合A目前规模为3.75亿元,最新净值1.0613,较上一交易日上涨2.95%,近一年上涨43.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200026818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767744712448,"stockEarnings":[{"period":"1week","weight":0.4566},{"period":"1month","weight":0.7707},{"period":"3month","weight":0.7049},{"period":"6month","weight":1.0654},{"period":"1year","weight":2.1301},{"period":"ytd","weight":0.44}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南翔宇医疗设备股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9531人(较上一季度增加51.24%)","perCapita":"16787股","listingDate":"2021-03-31","address":"河南省安阳市内黄县帝喾大道中段","registeredCapital":"16000万元","survey":" 河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。公司是同行业率先通过ISO9001和YY/T0287idtISO13485医疗器械质量管理体系、ISO14001环境管理体系、OHSAS18001职业健康安全管理体系和知识产权管理五个体系认证的企业。报告期末,公司已获得专利1,933项,参与起草或参与评定36个国家行业标准,获得省级科技成果248项。","listedPrice":28.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翔宇医疗,688626,翔宇医疗股票,翔宇医疗股票老虎,翔宇医疗股票老虎国际,翔宇医疗行情,翔宇医疗股票行情,翔宇医疗股价,翔宇医疗股市,翔宇医疗股票价格,翔宇医疗股票交易,翔宇医疗股票购买,翔宇医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}